04:31 PM EST, 12/11/2024 (MT Newswires) -- Metin Kurtoglu, Chief Technology Officer, on December 09, 2024, sold 13,664 shares in Cartesian Therapeutics ( RNAC ) for $345,134. Following the Form 4 filing with the SEC, Kurtoglu has control over a total of 51,033 shares of the company, with 51,033 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1453687/000145368724000145/xslF345X05/wk-form4_1733952508.xml